Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy

NCT01381497 · clinicaltrials.gov ↗

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: Combination therapy of sumatriptan and naproxen sodium (SumaRT/Nap)
DRUG: Triptan monotherapy

Sponsor

GlaxoSmithKline